Get research updatesDepression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
Going to Altitude With Anxious-depressive Symptoms
Read the official source — NCT05323864Going to Altitude With Anxious-depressive Symptoms - a Randomised Cross Over Trial in Individuals With Mental Disorders and Healthy Controls
This study assesses depression symptoms.
A-B-C Program: a Brief Intervention to Promote an Active Lifestyle by Addressing Behavioral Economics Cognitive Biases Among Sedentary Older Adults With Depressive Symptoms-a Randomized Controlled Trial
This study isn't recruiting yet.
Location not clearly listed
The Acute and Chronic Effects of Ecologic® Barrier on Depressive Symptoms and Neural Activation.
This study isn't recruiting yet.
In LondonHealth Qigong Alleviates Depressive Symptoms in Older Adults Through Enhanced Executive Attention: a Randomized Controlled Trial
This study isn't recruiting yet.
Location not clearly listed
This study evaluated the safety of Esketamine Nasal Spray for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamA Randomized, Double-Blind, Active-Controlled, International, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Flexibly-dosed Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression
This study was withdrawn before enrollment.
Location not clearly listedA Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamA Randomized, Double-blind, Multicenter, Active-Controlled Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Treatment-resistant Depression
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamA Double-blind, Randomized, Placebo-controlled, Parallel Group, Dose Frequency Study of Ketamine in Subjects With Treatment-resistant Depression
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamThis study evaluated the effectiveness of Esketamine for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including DaveA Randomized, Double-blind, Multicenter Active-controlled Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Subjects With Treatment-resistant Depression
This study has finished and is no longer accepting participants.
Multiple locations, including AtlantaWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.